Transderm Scop 1 mg per 3 d patch, extended release

Where it's made

This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Baxter Healthcare Corporation names for other drugs.

Recalls

• Apr 13, 2022 · Class II · Mckesson Medical-Surgical Inc. Corporate Office
  cGMP deviations: Temperature abuse
  Lots: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.
• Aug 24, 2016 · Class II · Sandoz Inc
  Defective Delivery System; reports of damaged product that may alter the predicted release of scopolamine following transdermal application.
  Lots: NDC 10019-553-02 (24 ct. carton) and NDC 10019-553-88 (patch); Lot #'s FV5908 and FX1520 both with expiry 06/2018; GB4910 and GC4210 both with expiry 09/2018; GE1927 with expiry 12/2018; GF7017 with expiry 01/2019 and GH8065 with expiry 02/2019.

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug

Scopolamine: every company that makes it

Form

patch, extended release

Strength

1 mg per 3 d

Approval

NDA NDA017874

On the market since

Dec 1, 2016

Package NDCs

10019-553-03 10019-553-04 10019-553-06 10019-553-90

Official label

DailyMed (National Library of Medicine), updated Jun 10, 2025

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?